MHRA approves prostate cancer imaging agent trofolastat
Approximately 55,100 new cases of prostate cancer are diagnosed every year in the UK
Read More
Tag: RoTecPSMA
- Acoramidis approved for heart condition treatment
- Genomics study launches to optimise childhood cancer care in Ireland
- UCL researchers launch congenital muscular dystrophy research programme
- Novavax shares positive real-world results for JN.1-adapted COVID-19 vaccine
- FDA approves Click’s digital therapeutic for episodic migraine
